Timothy S Mcconnell
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$10.3MFederal grants as PI16 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
16 awards · $10.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 25, 2021 | NIH | SBIR Phase II A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimer’s and Alzheimer’s Related Diseases | $994K | ISOPLEXIS CORPORATION |
| Jul 23, 2020 | NIH | SBIR Phase II Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation | $989K | ISOPLEXIS CORPORATION |
| Jun 5, 2020 | NIH | SBIR Phase II A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimer’s and Alzheimer’s Related Diseases | $1000K | ISOPLEXIS CORPORATION |
| Sep 17, 2019 | NIH | SBIR Phase I Age-dependent Single-cell Metabolomic and Proteomic Profiling of Human Immune System | $225K | ISOPLEXIS CORPORATION |
| Aug 29, 2019 | NIH | SBIR Phase II A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics | $600K | ISOPLEXIS CORPORATION |
| Jul 23, 2019 | NIH | SBIR Phase II Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation | $996K | ISOPLEXIS CORPORATION |
| Sep 13, 2018 | NIH | SBIR Phase II A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics | $600K | ISOPLEXIS CORPORATION |
| Aug 13, 2018 | NIH | SBIR Phase I A Combined High-Throughput Single-Cell Transcriptomic and Secretomic Assay for Neurodegenerative Disease Biomarker Discovery | $225K | ISOPLEXIS CORPORATION |
| Jun 7, 2018 | NIH | SBIR Phase II A single-cell device to capture and analyze rare T-cells from solid tumors. | $920K | ISOPLEXIS CORPORATION |
| Jun 1, 2018 | NIH | SBIR Phase II A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease | $846K | ISOPLEXIS CORPORATION |
| Sep 19, 2017 | NIH | SBIR Phase II A single-cell device to capture and analyze rare T-cells from solid tumors. | $991K | ISOPLEXIS CORPORATION |
| Sep 15, 2017 | NIH | SBIR Phase II A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics | $600K | ISOPLEXIS CORPORATION |
| Jul 31, 2017 | NIH | SBIR Phase II A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease | $846K | ISOPLEXIS CORPORATION |
| May 25, 2016 | NIH | SBIR Phase I A microchip to analyze trafficking leukocytes in Alzheimer’s disease patients | $164K | ISOPLEXIS CORPORATION |
| Apr 6, 2016 | NIH | SBIR Phase I Single-cell multi-protein device for informative cellular function evaluation | $164K | ISOPLEXIS CORPORATION |
| Aug 20, 2015 | NIH | SBIR Phase I A Single Cell Multi-Protein Device to Facilitate Cancer Immunotherapy | $182K | ISOPLEXIS CORPORATION |
Peer ranks
Federal funding#71
Awards as PI#48
Patents#505
Companies
- ISOPLEXIS CORPORATIONLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.